Home Featured Page 247

Featured

Latest

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative...

Virtual Reality and Psychedelic Synergy

Adding to their Expert Team, Albert Labs Announces the Formation and...

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat...

Silo Pharma Submits Application for NASDAQ up-listing

Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing...

PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity

Tryp Therapeutics Partners with Alcami for Proprietary Formulations

MindMed Announces Launch of Collaboration with Nextage Therapeutics’ Brain Targeting Liposome...

MagicMed to Be Acquired by Nasdaq-Listed Company

1...246247248...299 Page 247 of 299

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative...

Virtual Reality and Psychedelic Synergy

Adding to their Expert Team, Albert Labs Announces the Formation and...

PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat...

Silo Pharma Submits Application for NASDAQ up-listing

Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing...

PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity

Tryp Therapeutics Partners with Alcami for Proprietary Formulations

MindMed Announces Launch of Collaboration with Nextage Therapeutics’ Brain Targeting Liposome...

MagicMed to Be Acquired by Nasdaq-Listed Company

EDITOR PICKS

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY